(19)
(11) EP 1 212 414 A2

(12)

(88) Date of publication A3:
07.09.2001

(43) Date of publication:
12.06.2002 Bulletin 2002/24

(21) Application number: 00954771.2

(22) Date of filing: 25.08.2000
(51) International Patent Classification (IPC)7C12N 15/11, C07K 14/47, C12N 15/62, C07K 19/00, C07K 16/18, G01N 33/68, A61K 38/04
(86) International application number:
PCT/GB0003/265
(87) International publication number:
WO 0114/413 (01.03.2001 Gazette 2001/09)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 25.08.1999 GB 9920000

(71) Applicant: IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED
London WC2A 3NL (GB)

(72) Inventors:
  • GERMAIN, Stephane, Edouard
    F-92100 Boulogne-Billancourt (FR)
  • HILL, Caroline, Susan,Imperial Cancer Res. Fund
    London WC2A 3PX (GB)
  • HOWELL, Michael,Terence,Imperial Cancer Res. Fund
    London WC2A 3PX (GB)

(74) Representative: Miles, John Stephen et al
Eric Potter Clarkson,Park View House,58 The Ropewalk
Nottingham NG1 5DD
Nottingham NG1 5DD (GB)

   


(54) POLYPEPTIDES CAPABLE OF INTERACTING WITH THE SMAD PEPTIDE AND COMPRISING THE SEQUENCE PP(T/N)K